Piper Sandler Downgrades Seres Therapeutics (MCRB) to Neutral
Tweet Send to a Friend
Piper Sandler analyst Edward A. Tenthoff downgraded Seres Therapeutics (NASDAQ: MCRB) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
